Publications
| Num | Title |
|---|---|
| 1 | Buti M, Stepanova M, Palom A, Riveiro-Barciela M, Nader F, Roade L, Esteban R, Younossi Z. Chronic hepatitis D associated with worse patient-reported Outcomes than chronic hepatitis B. JHEP Rep. 2021 Mar 17;3(3):100280. doi:10.1016/j.jhepr.2021.100280. Erratum in: JHEP Rep. 2022 Jul 20;4(9):100526.PMID: 34041466; PMCID: PMC8141931. |
| 2 | Tampi RP, Wong VW, Wong GL, Shu SS, Chan HL, Fung J, Stepanova M, Younossi ZM. Modelling the economic and clinical burden of non-alcoholic steatohepatitis in East Asia: Data from Hong Kong. Hepatol Res. 2020 Sep;50(9):1024-1031. doi:10.1111/hepr.13535. Epub 2020 Jul 20. PMID: 32537840. |
| 3 | Castellanos-Fernández MI, Borges-González SA, Stepanova M, Infante-Velázquez ME, Ruenes-Domech C, González-Suero SM, Dorta-Guridi Z, Arus-Soler ER, Racila A, Younossi ZM. Health-related quality of life in Cuban patients with chronic liver disease: A real-world experience. Ann Hepatol. 2021 May-Jun;22:100277. doi:10.1016/j.aohep.2020.10.005. Epub 2020 Oct 29. PMID: 33130334. |
| 4 | Younossi ZM, Yilmaz Y, El-Kassas M, Duseja A, Hamid S, Esmat G, Méndez- Sánchez N, Chan WK, Singal AK, Lam B, Felix S, Younossi E, Verma M, Price JK, Nader F, Younossi I, Racila A, Stepanova M. The impact of the COVID-19 pandemic on patients with chronic liver disease: Results from the Global Liver Registry. Hepatol Commun. 2022 Jul 26:10.1002/hep4.2048. doi: 10.1002/hep4.2048. |
| 5 | Younossi ZM, Yilmaz Y, Yu ML, Wai-Sun Wong V, Fernandez MC, Isakov VA, Duseja AK, Mendez-Sanchez N, Eguchi Y, Bugianesi E, Burra P, George J, Fan JG, Papatheodoridis GV, Chan WK, Alswat K, Saeed HS, Singal AK, Romero-Gomez M, Gordon SC, Roberts SK, El Kassas M, Kugelmas M, Ong JP, Alqahtani S, Ziayee M, Lam B, Younossi I, Racila A, Henry L, Stepanova M; Global NASH Council. Clinical and Patient-Reported Outcomes From Patients With Nonalcoholic Fatty Liver Disease Across the World: Data From the Global Non-Alcoholic Steatohepatitis (NASH)/ Non-Alcoholic Fatty Liver Disease (NAFLD) Registry. Clin Gastroenterol Hepatol. 2021 Nov 9:S1542-3565(21)01183-6. doi: 10.1016/j.cgh.2021.11.004. |
| 6 | ) Younossi ZM, Ong JP, Takahashi H, Yilmaz Y, Eguc Hi Y, El Kassas M, Buti M, Diago M, Zheng MH, Fan JG, Yu ML, Wai-Sun Wong V, Alswat K, Chan WK, Mendez-Sanchez N, Burra P, Bugianesi E, Duseja AK, George J, Papatheodoridis GV, Saeed H, Castera L, Arrese M, Kugelmas M, Romero-Gomez M, Alqahtani S, Ziayee M, Lam B, Younossi I, Racila A, Henry L, Stepanova M; Global Nonalcoholic Steatohepatitis Council. A Global Survey of Physicians Knowledge About Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2022 Jun;20(6):e1456-e1468. doi: 10.1016/j.cgh.2021.06.048. Epub 2021 Jul 3. PMID:34229038. |
| 7 | Younossi ZM, Stepanova M, Ong J, Yilmaz Y, Duseja A, Eguchi Y, El Kassas M, Castellanos-Fernandez M, George J, Jacobson IM, Bugianesi E, Wong VW, Arrese M, de Ledinghen V, Romero-Gomez M, Mendez-Sanchez N, Ahmed A, Wong R, Papatheodoridis G, Serfaty L, Younossi I, Nader F, Ziayee M, Afendy A; Global NASH Council. Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease. Clin Gastroenterol Hepatol. 2019 Jul;17(8):1625-1633.e1. doi:10.1016/j.cgh.2018.11.033. Epub 2018 Nov 23. PMID: 30476585. |
| 8 | Younossi Z, Stepanova M, Ong JP, Jacobson IM, Bugianesi E, Duseja A, Eguchi Y, Wong VW, Negro F, Yilmaz Y, Romero-Gomez M, George J, Ahmed A, Wong R, Younossi I, Ziayee M, Afendy A; Global Nonalcoholic Steatohepatitis Council. Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates. Clin Gastroenterol Hepatol. 2019 Mar;17(4):748-755.e3. doi: 10.1016/j.cgh.2018.05.057. Epub 2018 Jun 14. PMID:29908364. |
Presentations
| Num | Title |
|---|---|
| 1 | Maria Stepanova, Marlen Fernandez, Yusuf Yilmaz, Ming-Lung Yu, Mohamed El Kassas, Gamal Esmat, Vasily Isakov, Vincent Wai-Sun Wong, Yuichiro Eguchi, Khaled Alswat, Nahum Mendez-Sanchez, Ajay Duseja, Maria Buti, Georgios Papatheodoridis, Saeed S Hamid, Jacob George, Elisabetta Bugianesi, Wah Kheong Chan, Ashwani K. Singal, Stuart C. Gordon, Jian-Gao Fan, Manuel Romero-Gomez, Ziad Younes, Stuart Roberts, Aijaz Ahmed, Janus P. Ong, Brian P. Lam, Marcelo Kugelmas, Saleh Alqahtani, Issah Younossi, Fatema Nader, Andrei Racila, Zobair M Younossi. DEPRESSION AND EMOTIONAL DISTRESS IN PATIENTS WITH CHRONIC LIVER DISEASE (CLD): DATA FROM THE GLOBAL LIVER REGISTRY™ (GLR™), American Association for the Study of Liver Diseases. Washington, D.C. 2022. |
| 2 | Zobair M Younossi, Yusuf Yilmaz, Ming-Lung Yu, Khaled Alswat, Maria Buti, Marlen Castellanos-Fernandez, Georgios Papatheodoridis, Saeed S Hamid, Mohamed El Kassas, Wah Kheong Chan, Ajay Duseja, Stuart C. Gordon, Vasily Isakov, Stuart Roberts, Jian-Gao Fan, Yuichiro Eguchi, Ashwani K. Singal, Manuel Romero-Gomez, Brian P. Lam, Aijaz Ahmed, Janus P. Ong, Saleh Alqahtani, Issah Younossi, Fatema Nader, Andrei Racila, Maria Stepanova. CLINICAL AND PATIENT-REPORTED OUTCOME (PRO) PROFILE OF PATIENTS WITH HEPATITIS B VIRAL (HBV) INFECTION FROM THE GLOBAL LIVER REGISTRY™ (GLR™), American Association for the Study of Liver Diseases. Washington, D.C. 2022. |
| 3 | Zobair M Younossi, Yusuf Yilmaz, Mohamed El Kassas, Ajay Duseja, Saeed S Hamid, Gamal Esmat, Nahum Mendez-Sanchez, Wah Kheong Chan, Ashwani K. Singal, Janus P. Ong, Brian P. Lam, Sean C. Felix, Elena Younossi, Manisha Verma, Jillian Kallman Price, Fatema Nader, Issah Younossi, Andrei Racila, Maria Stepanova. Negative Impact of COVID-19 Infection Related to Life Disruption Events and Health Scores on Patients with Chronic Liver Disease, European Association for the Study of the Liver. London, UK. June 24, 2022.. |
| 4 | Zobair M Younossi, Yusuf Yilmaz, Ming-Lung Yu, Vincent Wai-Sun Wong, Marlen Castellanos-Fernandez, Vasily Isakov, Ajay Duseja, Nahum Mendez-Sanchez, Yuichiro Eguchi, Elisabetta Bugianesi, Patrizia Burra, Jacob George, Jian-Gao Fan, George A Papandreou, Wah Kheong Chan, Khaled Alswat, Saeed S Hamid, Ashwani K. Singal, Manuel Romero-Gomez, Stuart C. Gordon, Stuart Roberts, Mohamed El Kassas, Marcelo Kugelmas, Janus P. Ong, Saleh Alqahtani, Mariam Ziayee, Brian P. Lam, Issah Younossi, Andrei Racila, Linda Henry, Maria Stepanova. Lean Non-Alcoholic Fatty Liver Disease Patients from the Global NASH Registry, European Association for the Study of the Liver. London, UK. June 23, 2022.. |
| 5 | Zobair M Younossi, Yusuf Yilmaz, Mohamed El Kassas, Ajay Duseja, Saeed S Hamid, Gamal Esmat, Nahum Mendez-Sanchez, Wah Kheong Chan, Ashwani K. Singal, Brian P. Lam, Sean C. Felix, Elena Younossi, Manisha Verma, Jillian Kallman Price, Fatema Nader, Janus P. Ong, Issah Younossi, Andrei Racila, Mariam Ziayee, Arian Afendy, Maria Stepanova. COVID-19 PANDEMIC AND CHRONIC LIVER DISEASE (CLD), American Association for the Study of Liver Diseases. Virtual, November 2021. |
| 6 | Zobair M Younossi, Yusuf Yilmaz, Vincent Wai-Sun Wong, Marlen Fernandez, Elisabetta Bugianesi, Patrizia Burra, Ming-Lung Yu, Wah Kheong Chan, Vasily Isakov, Ajay Duseja, Nahum Mendez-Sanchez, Yuichiro Eguchi, Jacob George, Jian-Gao Fan, Georgios Papatheodoridis, Khaled Alswat, Saeed S Hamid, Ashwani K. Singal, Marcelo Kugelmas, Janus P. Ong, Saleh Alqahtani, Mariam Ziayee, Brian P. Lam, Issah Younossi, Andrei Racila, Linda Henry, Maria Stepanova. FATIGUE AND NON-ALCOHOLIC FATTY LIVER DISEASE: DATA FROM THE GLOBAL NASH REGISTRY, American Association for the Study of Liver Diseases. Virtual, November 2021. |
| 7 | Zobair M Younossi, Yusuf Yilmaz, Mohamed El Kassas, Ajay Duseja, Saeed S Hamid, Gamal Esmat, Nahum Mendez-Sanchez, Wah Kheong Chan, Ashwani K. Singal, Brian P. Lam, Sean C. Felix, Elena Younossi, Manisha Verma, Jillian Kallman Price, Fatema Nader, Issah Younossi, Andrei Racila, Maria Stepanova. The Impact of COVID-19 Pandemic on Patients with Chronic Liver Disease (CLD): Data from the Global Registry, European Association for the Study of the Liver. Virtual, June 2021. |
| 8 | Zobair M Younossi, Hirokazu Takahashi, Yuichiro Eguchi, Yusuf Yilmaz, Mohamed El Kassas, Maria Buti, Moises Diago, Ming-Hua Zheng, Jian-Gao Fan, Vincent Wai-Sun Wong, Khaled Alswat, Wah Kheong Chan, Nahum Mendez-Sanchez, Patrizia Burra, Elisabetta Bugianesi, Ajay Duseja, Jacob George, Georgios Papatheodoridis, Saeed S Hamid, Laurent Castera, Marco Arrese, Marcelo Kugelmas, Janus P. Ong, Manuel Romero-Gomez, Saleh Alqahtani, Mariam Ziayee, Brian P. Lam, Issah Younossi, Andrei Racila, Linda Henry, Maria Stepanova. A GLOBAL SURVEY OF PHYSICIANS KNOWLEDGE ABOUT NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), Digestive Disease Week. Virtual, May 2021. |
| 9 | Zobair M Younossi, Yusuf Yilmaz, Ming-Lung Yu, Vincent Wai-Sun Wong, Marlen Fernandez, Vasily Isakov, Ajay Duseja, Nahum Mendez-Sanchez, Yuichiro Eguchi, Elisabetta Bugianesi, Patrizia Burra, Jacob George, Jian-Gao Fan, Georgios Papatheodoridis, Wah Kheong Chan, Khaled Alswat, Saeed S Hamid, Ashwani K. Singal, Manuel Romero-Gomez, Stuart C. Gordon, Stuart Roberts, Mohamed El Kassas, Marcelo Kugelmas, Janus P. Ong, Saleh Alqahtani, Mariam Ziayee, Brian P. Lam, Issah Younossi, Andrei Racila, Linda Henry, Maria Stepanova. CLINICAL PRESENTATION OF LEAN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) ACROSS THE WORLD: DATA FROM THE GLOBAL NASH REGISTRY, Digestive Disease Week. Virtual, May 2021. |
| 10 | Ming-Lung Yu, Mohamed El Kassas, Yusuf Yilmaz, Marlen Castellanos-Fernandez, Maria Buti, George A Papandreou, Ajay Duseja, Khaled Alswat, Vasily Isakov, Wah Kheong Chan, Saeed S Hamid, Stuart C. Gordon, Jian-Gao Fan, Yuichiro Eguchi, Ashwani K. Singal, Aijaz Ahmed, Marcelo Kugelmas, Janus P. Ong, Saleh Alqahtani, Brian P. Lam, Issah Younossi, Fatema Nader, Andrei Racila, Maria Stepanova, Zobair M Younossi. CLINICAL PRESENTATION AND PATIENT-REPORTED OUTCOMES IN PATIENTS WITH CHRONIC VIRAL HEPATITIS: DATA FROM THE GLOBAL LIVER REGISTRY™, Digestive Disease Week. Virtual, May 2021. |
| 11 | Jillian Kallman, Natalie VanderNoot, Carey Escheik, Patrick Austin, James M. Estep, Lynn Gerber, Zobair M Younossi. PRINCIPAL COMPONENTS ANALYSIS (PCA) IN CHRONIC LIVER DISEASE (CLD) REVEALS THREE COMPONENT MODEL HIGHLIGHTING DISCRETE CONTRIBUTIONS BY SARCOPENIA CRITERIA MEASURES AND SERUM MYOKINES, Digestive Disease Week. Virtual, May 2021. |
| 12 | Zobair M Younossi, Hirokazu Takahashi, Yuichiro Eguchi, Yusuf Yilmaz, Mohamed El Kassas, Ming-Hua Zheng, Jian-Gao Fan, Vincent Wai-Sun Wong, Khaled Alswat, Wah Kheong Chan, Nahum Mendez-Sanchez, Patrizia Burra, Elisabetta Bugianesi, Ajay Duseja, Maria Buti, Moises Diago, Manuel Romero-Gomez, Jacob George, Georgios Papatheodoridis, Saeed S Hamid, Laurent Castera, Marco Arrese, Marcelo Kugelmas, Janus P. Ong, Mariam Ziayee, Issah Younossi, Andrei Racila, Linda Henry, Maria Stepanova. SIGNIFICANT KNOWLEDGE GAP ABOUT NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN REAL-WORLD PRACTICES: A GLOBAL SURVEY OF HEPATOLOGISTS, GASTROENTEROLOGISTS, ENDOCRINOLOGISTS AND PRIMARY CARE PHYSICIANS, American Association for the Study of Liver Diseases. Virtual, November 2020. |
| 13 | Zobair M Younossi, Stephen A. Harrison, Philip N Newsome, Wah Kheong Chan, Yusuf Yilmaz, Ming-Hua Zheng, Vincent Wai-Sun Wong, Magdy Elkhashab, Kathryn Kersey, Robert P. Myers, Julie Foucquier, Aymeric Labourdette, Marie Destro, Celine Fournier, Veronique Miette, Laurent Sandrin, Arun J. Sanyal. IMPROVING DIAGNOSIS OF CIRRHOSIS IN PATIENTS WITH NAFLD BY COMBINING LIVER STIFFNESS MEASUREMENT (LSM) BY VIBRATION-CONTROLLED TRANSIENT ELASTOGRAPHY (VCTE) AND ROUTINE BIOMARKERS: A GLOBAL DERIVATION AND VALIDATION STUDY, American Association for the Study of Liver Diseases. Virtual, November 2020. |
| 14 | Yusuf Yilmaz, Ming-Lung Yu, Brian P. Lam, Maria Buti, Georgios Papatheodoridis, Wah Kheong Chan, Ajay Duseja, Khaled Alswat, Mohamed El Kassas, Saeed S Hamid, Vasily Isakov, Stuart C. Gordon, Stuart Roberts, Jian-Gao Fan, Yuichiro Eguchi, Aijaz Ahmed, Ashwani K. Singal, Manuel Romero-Gomez, Issah Younossi, Fatema Nader, Andrei Racila, Maria Stepanova, Janus P. Ong, Saleh Alqahtani, Zobair M Younossi. THE IMPACT OF CHRONIC HEPATITIS B ON PATIENT-REPORTED OUTCOMES FROM THE GLOBAL LIVER REGISTRY™, American Association for the Study of Liver Diseases. Virtual, November 2020. |
| 15 | Ming-Lung Yu, Mohamed El Kassas, Brian P. Lam, Gamal Esmat, Marlen Fernandez, Maria Buti, Georgios Papatheodoridis, Vasily Isakov, Ajay Duseja, Yusuf Yilmaz, Stuart C. Gordon, Saeed S Hamid, Manuel Romero-Gomez, Wah Kheong Chan, Issah Younossi, Fatema Nader, Andrei Racila, Maria Stepanova, Janus P. Ong, Saleh Alqahtani, Zobair M Younossi. PATIENT-REPORTED OUTCOMES IN PATIENTS WITH CHRONIC HEPATITIS С: DATA FROM THE GLOBAL LIVER REGISTRY™, American Association for the Study of Liver Diseases. Virtual, November 2020. |
| 16 | Zobair M Younossi, Yusuf Yilmaz, Ming-Lung Yu, Vasily Isakov, Ajay Duseja, Yuichiro Eguchi, Jacob George, Elisabetta Bugianesi, Georgios Papatheodoridis, Wah Kheong Chan, Khaled Alswat, Saeed S Hamid, Manuel Romero-Gomez, Stuart C. Gordon, Stuart Roberts, Mohamed El Kassas, Aijaz Ahmed, Brian P. Lam, Saleh Alqahtani, Issah Younossi, Fatema Nader, Janus P. Ong, Maria Stepanova. CLINICAL AND PATIENT-REPORTED OUTCOMES DATA OF NON-ALCOHOLIC FATTY LIVER DISEASE: LONGITUDINAL DATA FROM THE GLOBAL NASH REGISTRY™, American Association for the Study of Liver Diseases. Virtual, November 2020. |
| 17 | Zobair M Younossi, Yusuf Yilmaz, Mohamed El Kassas, Vincent Wai-Sun Wong, Ajay Duseja, Nahum Mendez-Sanchez, Jacob George, Wah Kheong Chan, Laurent Castera, Marco Arrese, Khaled Alswat, Hirokazu Takahashi, Manuel Romero-Gomez, Janus P. Ong, Mariam Ziayee, Issah Younossi, Andrei Racila, Maria Stepanova. Significant knowledge gap about non-alcoholic fatty liver disease (NAFLD) in real-world practices: A global survey of hepatologists, gastroenterologists, endocrinologists and primary care physicians, European Association for the Study of the Liver. Virtual, August 2020. |
| 18 | Zobair M Younossi, Yusuf Yilmaz, Ming-Lung Yu, Mohamed El Kassas, Marlen Castellanos-Fernandez, Vincent Wai-Sun Wong, Vasily Isakov, Ajay Duseja, Nahum Mendez-Sanchez, Georgios Papatheodoridis, Wah Kheong Chan, Jacob George, Jian-Gao Fan, Elisabetta Bugianesi, Yuichiro Eguchi, Ziad Younes, Manuel Romero-Gomez, Stuart Roberts, Stuart C. Gordon, Saeed S Hamid, Aijaz Ahmed, Janus P. Ong, Saleh Alqahtani, Brian P. Lam, Mariam Ziayee, Issah Younossi, Fatema Nader, Andrei Racila, Maria Stepanova. The clinical and patient reported outcomes (pros) profile of patients with non-alcoholic fatty liver disease (nafld) from real-world practices varies across the world, European Association for the Study of the Liver. Virtual, August 2020. |
| 19 | Lynn Gerber, James Minhui Paik, Carey Escheik, Leyla de Avila, Pegah Golabi, Zobair M Younossi. THE CONTRIBUTION OF SARCOPENIA AND PHYSICAL INACTIVITY TO MORTALITY IN PEOPLE WITH NON-ALCOHOLIC FATTY LIVER DISEASE, Digestive Disease Week. Virtual, May 2020. |
| 20 | Zobair M Younossi, Ming-Lung Yu, Yusuf Yilmaz, Mohamed El Kassas, Marlen Castellanos-Fernandez, Vincent Wai-Sun Wong, Vasily Isakov, Ajay Duseja, Nahum Mendez-Sanchez, Georgios Papatheodoridis, Wah Kheong Chan, Jacob George, Jian-Gao Fan, Elisabetta Bugianesi, Yuichiro Eguchi, Ziad Younes, Manuel Romero-Gomez, Stuart Roberts, Stuart C. Gordon, Saeed S Hamid, Aijaz Ahmed, Janus P. Ong, Saleh Alqahtani, Brian P. Lam, Mariam Ziayee, Issah Younossi, Fatema Nader, Andrei Racila, Linda Henry, Maria Stepanova. THE IMPACT OF FATIGUE ON PATIENT-REPORTED OUTCOMES (PRO) IN PATIENTS WITH CHRONIC LIVER DISEASE (CLD): DATA FROM THE GLOBAL LIVER REGISTRY (GLR), Digestive Disease Week. Virtual, May 2020. |
| 21 | Zobair M Younossi, Yusuf Yilmaz, Ming-Lung Yu, Mohamed El Kassas, Marlen Castellanos-Fernandez, Vincent Wai-Sun Wong, Vasily Isakov, Ajay Duseja, Nahum Mendez-Sanchez, Georgios Papatheodoridis, Wah Kheong Chan, Jacob George, Jian-Gao Fan, Elisabetta Bugianesi, Yuichiro, Eguchi, Ziad Younes, Manuel Romero-Gomez, Stuart Roberts, Stuart C. Gordon, Saeed S Hamid, Aijaz Ahmed, Janus P. Ong, Saleh Alqahtani, Brian P. Lam, Mariam Ziayee, Issah Younossi, Fatema Nader, Andrei Racila, Maria Stepanova. The Clinical and Patient-Reported Outcomes (PRO) Profile of Patients with Chronic Liver Disease (CLD) in Asian Countries: Data from Real-World Practices Varies Across the World, Asian Pacific Association for the Study of Liver. Virtual, September 2020. |
| 22 | Zobair M Younossi, Ming-Lung Yu, Mohamed El Kassas, Gamal Esmat, Yusuf Yilmaz, Marlen Fernandez, Ajay Duseja, Vasily Isakov, Maria Buti, Nahum Mendez-Sanchez, Georgios Papatheodoridis, Wah Kheong Chan, Jacob George, Elisabetta Bugianesi, Manuel Romero-Gomez, Stuart Roberts, Ziad Younes, Vincent Wai-Sun Wong, Jian Aresse, Fatema Nader, Andrei Racila, Linda Henry, Maria Stepanova. CLINICAL AND PATIENT-REPORTED OUTCOMES DATA FOR PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NON-ALCOHOLIC STEATOHEPATITIS (NASH) ACROSS THE WORLD: DATA FROM THE GLOBAL NASH REGISTRY, American Association for the Study of Liver Diseases. Boston, MA. 2019.. |
| 23 | Zobair M Younossi, Ming-Lung Yu, Mohamed El Kassas, Gamal Esmat, Yusuf Yilmaz, Marlen Fernandez, Ajay Duseja, Vasily Isakov, Maria Buti, Nahum Mendez-Sanchez, Georgios Papatheodoridis, Wah Kheong Chan, Jacob George, Elisabetta Bugianesi, Manuel Romero-Gomez, Stuart Roberts, Ziad Younes, Vincent Wai-Sun Wong, Jian Aresse, Mary E. Rinella, Saeed S Hamid, Issah Younossi, Brian P. Lam, Mariam Ziayee, Fatema Nader, Andrei Racila, Linda Henry, Maria Stepanova. CLINICAL AND PATIENT-REPORTED OUTCOMES (PROs) IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS (HBV) INFECTION SEEN IN REAL-WORLD PRACTICES ACROSS THE WORLD: DATA FROM THE GLOBAL LIVER REGISTRY, American Association for the Study of Liver Diseases. Boston, MA. 2019.. |
| 24 | Maria Buti, Maria Stepanova, Adriana Palom, Mar Riveriro, Rafael Esteban, Zobair M Younossi. HEPATITIS DELTA INFECTION IS ASSOCIATED WITH IMPAIRMENT OF PATIENT REPORTED OUTCOMES (PROs), American Association for the Study of Liver Diseases. Boston, MA. 2019.. |
| 25 | Zobair M Younossi, Ming-Lung Yu, Mohamed El Kassas, Gamal Esmat, Yusuf Yilmaz, Marlen Fernandez, Ajay Duseja, Vasily Isakov, Maria Buti, Nahum Mendez-Sanchez, Georgios Papatheodoridis, Wah Kheong Chan, Jacob George, Elisabetta Bugianesi, Manuel Romero-Gomez, Stuart Roberts, Ziad Younes, Vincent Wai-Sun Wong, Jian-Gao Fan, Yuichiro Eguchi, Stuart C. Gordon, Aijaz Ahmed, Janus P. Ong, Ira M. Jacobson, Marco Arrese, Mary E. Rinella, Saeed S Hamid, Issah Younossi, Brian P. Lam, Mariam Ziayee, Fatema Nader, Andrei Racila, Linda Henry, Maria Stepanova. SEVERE IMPAIRMENT OF PATIENT-REPORTED OUTCOMES (PROs) IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS (HCV) INFECTION SEEN IN REAL-WORLD PRACTICES ACROSS THE WORLD: DATA FROM THE GLOBAL LIVER REGISTRY, American Association for the Study of Liver Diseases. Boston, MA. 2019.. |
| 26 | Zobair M Younossi, Ming-Lung Yu, Mohamed El Kassas, Gamal Esmat, Yusuf Yilmaz, Marlen Fernandez, Ajay Duseja, Vasily Isakov, Maria Buti, Nahum Mendez-Sanchez, Georgios Papatheodoridis, Wah Kheong Chan, Jacob George, Elisabetta Bugianesi, Manuel Romero-Gomez, Stuart Roberts, Ziad Younes, Vincent Wai-Sun Wong, Jian-Gao Fan, Yuichiro Eguchi, Stuart C. Gordon, Aijaz Ahmed, Janus P. Ong, Ira M. Jacobson, Marco Arrese, Mary E. Rinella, Saeed S Hamid, Issah Younossi, Brian P. Lam, Mariam Ziayee, Fatema Nader, Andrei Racila, Linda Henry, Maria Stepanova. DIFFERENCES IN THE CLINICAL PROFILE OF THE MOST COMMON CAUSES OF CHRONIC LIVER DISEASE (CLD) ACROSS THE WORLD: DATA FROM THE GLOBAL LIVER REGISTRY., American Association for the Study of Liver Diseases. Boston, MA. 2019.. |
| 27 | Zobair M Younossi, Maria Stepanova, Janus P. Ong, Yusuf Yilmaz, Ajay Duseja, Yuichiro Eguchi, Mohamed El Kassas, Marlen Fernandez, Jacob George, Ira M. Jacobson, Elisabetta Bugianesi, Vincent Wai-Sun Wong, Marco Arrese, Victor de Ledinghen, Manuel Romero-Gomez, Nahum Mendez-Sanchez, Aijaz Ahmed, Robert John Wong, Georgios Papatheodoridis, Lawrence Serfaty, Philippe Mathurin, Issah Younossi, Fatema Nader, Mariam Ziayee, Arian Afendy. Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcoholic Fatty Liver Disease (AFLD): The Impact of Alcohol Consumption and Metabolic Syndrome on Mortality, American Association for the Study of Liver Diseases. San Francisco, CA. November 11, 2018.. |
| 28 | Haley Bush, Pegah Golabi, Munkhzul Otgonsuren, Brian P. Lam, Manirath Srishord, Nila Rafiq, Zobair M Younossi. Non-alcoholic Fatty Liver Is Increasingly Contributing the Number of Cases of Liver Disease (LD) Seen in the Emergency Departments (ED) in the United States (U.S.), Digestive Disease Week. McCormick Place, Chicago, IL, May 9, 2017. |
| 29 | Zobair M Younossi, Maria Stepanova, Andrew J. Muir, Maria Buti, K. Rajender Reddy, Steven L. Flamm, Issah Younossi, Sharon Hunt. The long-term impact of sustained virologic response (SVR) on patient-reported outcomes in cirrhotics with Hepatitis C infection, European Association for the Study of the Liver. . |
| 30 | Zobair M Younossi, Maria Stepanova, Brian P. Lam, Jillian Kallman, Leyla de Avila, Andrei Racila. PATIENT-REPORTED OUTCOMES (PROs) IN PATIENTS WITH CHRONIC HEPATITIS B WITH OR WITHOUT VIREMIA, Asian Pacific Association for the Study of Liver. Shanghai, China. February 16, 2017.. |
| 31 | Zobair M Younossi, Maria Stepanova, Linda Henry, Issah Younossi, Atsushi Tanaka, Yuichiro, Eguchi, Norifumi Kawada, Andrei Racila, Sharon Hunt. The prevalence and costs associated with clinically overt extrahepatic manifestations of hepatitis C virus infection in Japan, Asian Pacific Association for the Study of Liver. Shanghai, China. February 16, 2017.. |
| 32 | Zobair M Younossi, Deidre Blissett, Rob Blissett, Maria Stepanova, Linda Henry, Youssef Younossi, Rachel Beckerman, Sharon Hunt. The Economic and Clinical Burden of Non-alcoholic Fatty Liver Disease (NAFLD) in the United States and Europe: A Steady-State Prevalence Model (abstract), American Association for the Study of Liver Diseases. Boston, November 14, 2016. |
| 33 | Maria Stepanova, Leyla de Avila, Mariam Afendy, Issah Younossi, Huong T. Pham, Rebecca Cable, Lynn Gerber, Zobair M Younossi. Extensive Economic and Quality of Life Burden of Viral Hepatitis (VH): The Data from the U.S. Medical Expenditure Panel Survey (MEPS), American Association for the Study of Liver Diseases. Boston, November 11, 2016. |
| 34 | Zobair M Younossi, Issah Younossi, Huong T. Pham, Maria Stepanova, Brian P. Lam, Sharon Hunt. Development and Validation of a Disease-Specific Health-Related Quality (HRQL) Instrument for Patients with Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH): The CLDQ-NAFLD, American Association for the Study of Liver Diseases. Boston, November 14, 2016. |
| 35 | Zobair M Younossi, Deidre Blissett, Rob Blissett, Linda Henry, Youssef Younossi, Rachel Beckerman, Sharon Hunt. In The Era of Highly Effective Direct Acting Anti-Viral Agents, Screening The Entire United States Population for Hepatitis C is Cost Effective, American Association for the Study of Liver Diseases. Boston, November 12, 2016. |
| 36 | Zobair M Younossi, Maria Stepanova, Fatema Nader, Sharon Hunt, Christophe Bureau, Neil Inhaber, Rajiv Jalan. Patients with Refractory Ascites Treated with alfapump® System (AP) have Better Health-related Quality of Life (HRQL) as Compared to those Treated with Large Volume Paracentesis (LVP): Results of a Multicenter Randomized Controlled Study, American Association for the Study of Liver Diseases. Boston, November 11, 2016. |
| 37 | Zobair M Younossi, Munkhzul Otgonsuren, Linda Henry, Fatema Nader, Andrei Racila, Sharon Hunt. The Extra Hepatic Manifestation of Hepatitis C Virus in the Asian Countries- A Systematic Review of the Epidemiologic Burden, Asian Pacific Digestive Week. Kobe, November 02, 2016. |
| 38 | Zobair M Younossi, Maria Stepanova, Sharon Hunt. Development of A Validated Disease-Specific Health-Related Quality (HRQL) Instrument for Patients with Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH): CLDQ-NAFLD (ADA), American Diabetes Association. New Orleans, La, June 10, 2016. |
| 39 | Aaron B. Koenig, Maria Stepanova, Sammy Saab, Aijaz Ahmed, Robert John Wong, Trevor Gogoll, Zobair M Younossi. Long-Term Outcomes of Lung Transplantation in Patients with Hepatitis C Infection: The Data from the U.S. Transplant Registry, Digestive Disease Week. San Diego, CA, May 21, 2016. |
| 40 | Zobair M Younossi, Linda Henry, Maria Stepanova, Youssef Younossi, Sharon Hunt, Rachel Beckerman. Non-alcoholic Fatty Liver Disease (NAFLD) and Type 2 Diabetes (DM): A Costly Combination, Digestive Disease Week. San Diego, CA, May 21, 2016. |
| 41 | Zobair M Younossi, Linda Henry, Maria Stepanova, Youssef Younossi, Andrei Racila, Sharon Hunt, Rachel Beckerman. THE ECONOMIC AND CLINICAL BURDEN OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN THE UNITED STATES, European Association for the Study of the Liver. Barcelona, Spain, April 2016. |
| 42 | Maria Stepanova, Mehmet Sayiner, Leyla de Avila, Zahra Younoszai, Andrei Racila, Zobair M Younossi. LONG-TERM OUTCOMES IN LIVER TRANSPLANT RECIPIENTS TRANSPLANTED FROM HCV-POSITIVE DONORS, European Association for the Study of the Liver. Barcelona, Spain, April 2016. |
| 43 | Zobair M Younossi, Maria Stepanova, Linda Henry, Fatema Nader, Sharon Hunt. Predictors of Adherence to Treatment of Chronic Hepatitis C (CHC), Asian Pacific Association for the Study of Liver. Tokyo, Japan, February 20, 2016. |
| 44 | Aaron B. Koenig, Dinan Abdelatif, Yousef Fazel, Mark Wymer, Linda Henry, Zobair M Younossi. A Meta-analytic Assessment of Worldwide Prevalence of Non Alcoholic Fatty Liver Disease (NAFLD) and Associated Co-morbidities, American Association for the Study of Liver Diseases. San Francisco, November 13, 2015. |
| 45 | Zobair M Younossi, Maria Stepanova, Linda Henry, Issah Younossi, Ali Weinstein, Fatema Nader, Sharon Hunt. Reduced Work Productivity (WP), Absenteeism and Presenteeism of Patients Infected with Hepatitis C Virus (HCV) are Independently Predicted by Physical Component of Patient-Reported Outcomes (PROs), American Association for the Study of Liver Diseases. San Francisco, November 13, 2015. |
| 46 | Zobair M Younossi, Maria Stepanova, Linda Henry, Fatema Nader, Sharon Hunt. Interferon (IFN), Ribavirin (RBV), Duration of Treatment and Baseline Patient-Reported Outcomes (PROs) Predict Adherence to the New Regimens for Treatment of Chronic Hepatitis C (CH-C), American Association for the Study of Liver Diseases. San Francisco, November 13, 2015. |
| 47 | Zobair M Younossi, Maria Stepanova, Linda Henry, Fatema Nader, Sharon Hunt. Adherence to Interferon (IFN) and Ribavirin (RBV)-Free Regimens for Treatment of Chronic Hepatitis C (CH-C): Are There Any Associations with Clinical and Patient-Reported Outcomes (PROs)? , American College Gastroenterology. Honolulu, HI, October 16, 2015. |
| 48 | Zobair M Younossi, Maria Stepanova, Linda Henry, Fatema Nader, Sharon Hunt. The Impact of Interferon (IFN)-Free Regimens for Treatment of Hepatitis C Viral (HCV) Infection on Health Related Quality of Life (HRQL), Fatigue and Work Productivity, American College Gastroenterology. Honolulu, HI, October 16, 2015. |
| 49 | Lynn Gerber, James M. Estep, Elzafir Elsheikh Abdelrahman, Maria Stepanova, Carey Escheik, Zobair M Younossi. Improvement of Central and Peripheral Fatigue and Associated Biomarkers After Sustained Virologic Response (SVR) with Ledipasvir (LDV)/Sofosbuvir (SOF) in Patients with Chronic Hepatitis C Virus (CH-C), Digestive Disease Week. Washington, D.C., May 16, 2015. |
| 50 | Zobair M Younossi, Nathaniel Smith, Maria Stepanova, Ashley S. Brown, Maria Buti, Stefano Fagiuoli, Stefan Mauss, William Rosenberg, Ankur Srivastava, Yushan Jiang, Rachel Beckerman. The Impact of Sustained Viral Eradication on the Work Productivity of Patients with Chronic Hepatitis C (CHC) from the Five Western European Countries and the United States, Digestive Disease Week. Washington, D.C., May 16, 2015. |
| 51 | Zobair M Younossi, Maria Stepanova, Linda Henry, Fatema Nader. The Quality of Life Journey for Patients with Chronic Hepatitis C: From Interferon and Ribavirin to Interferon-Free and Ribavirin-Free Regimens, European Association for the Study of the Liver. Vienna, Austria, April 2015. |
| 52 | Zobair M Younossi, Maria Stepanova, Linda Henry, Haesuk Park, Andrei Racila, Zahra Younoszai, Sharon Hunt. Direct Medical Costs Associated with the Extrahepatic Manifestations of Hepatitis C Infection in the United States, European Association for the Study of the Liver. Vienna, Austria, April 2015. |
| 53 | Maria Buti, Maria Stepanova, Zobair M Younossi. Impact of Sofosbuvir/Ledipasvir treatment on the economic burden associated to productivity loss due to chronic hepatitis C in Spain, ASOCIACIÓN ESPAÑOLA DEL ESTUDIO DEL HÍGADO. Madrid. February 01, 2015. |
| 54 | Zobair M Younossi, Maria Stepanova, Sammy Saab, Kameron Tavakolian, Brian P. Lam, Manirath Srishord, Chapy Venkatesan, James Cooper, Homan Wai, Linda Henry. Outcomes of Liver Transplantation in Patients with Hepatitis C and Hepatocellular Carcinoma (HCC): The U.S. Transplant Registry Data, American Association for the Study of Liver Diseases. Boston, MA, November 2014. |
| 55 | Ali Weinstein, Heibatollah Baghi, Carey Escheik, Lynn Gerber, Zobair M Younossi. Two Types of Fatigue in Subjects with Chronic Liver Disease Can Be Distinguished Through Correlations with Physical Activity and Mental Symptoms, American Association for the Study of Liver Diseases. Boston, MA, November 2014. |
| 56 | Linda Henry, Kathleen Whitly, Kerry Dhakal, Libby Samuel, Lois Culler, Melinda Byrns, Sharon Hunt, Zobair M Younossi. A Systematic Review Assessing the Impact of Chronic Hepatitis C (CH-C) on Health Related Quality of Life (HRQL) and Patient Reported Outcomes (PROs), American College Gastroenterology. Philadelphia, PA, October 2014. |
| 57 | Maria Stepanova, Sharon Hunt, Sammy Saab, Spencer Frost, Thomas Jeffers, Zobair M Younossi. Outcomes of Liver Transplantation in the United States: What Has Changed Over the Last 25 Years?, Digestive Disease Week. Chicago, IL, May 2014. |
| 58 | Maria Stepanova, Sammy Saab, Sharon Hunt, Thomas Jeffers, Shirley Kalwaney, Zobair M Younossi. Donor's and recipient's diabetes are independently associated with mortality in liver transplant recipients, European Association for the Study of the Liver. London, UK, April 2014. |